(NAPSI)—For the nearly 40 million Americans living with diabetes, the threat to their vision unfolds quietly, often without ...

Diabetic retinopathy, a type of diabetic eye disease, is one of the leading causes of blindness in the United States. Despite this, almost 40% of people with diabetes don’t get an annual eye exam. But ...

You can start seeing dark spots in your vision if you have diabetic retinopathy, and it can lead to blindness if not treated early enough. Share on Pinterest hareluya/Shutterstock Diabetic retinopathy ...

While eye care and regular eye exams are important for everyone, they're particularly vital for people with diabetes.

Share on Pinterest A study finds 1 in 4 people with diabetes have diabetic retinopathy. Azman Jaka/Getty Images A new study finds a quarter of people with diabetes have retinopathy. Diabetic ...

I learned I had diabetic retinopathy in 2004. Unfortunately, my diagnosis came a little too late, and I lost most of the vision in my right eye. Today, when I do advocacy work, I stress how important ...

Diabetic retinopathy, a leading cause of vision loss affecting millions, damages the retina's blood vessels. Experts ...

On behalf of our sponsors at the American Society of Retina Specialists, Everyday Northwest's Nicole DeCosta spoke with Geoffrey Emerson — MD, PhD, FASRS, and President of the American Society of ...

A more powerful version of an anti-inflammatory molecule already circulating in our blood may help protect our vision in the face of diabetes. Diabetic retinopathy resulting from high circulating ...

Diabetic retinopathy is a complication of diabetes that affects vision. Nonproliferative diabetic retinopathy describes the earlier stages of the condition before it progresses into the final and most ...

Diabetic retinopathy is an eye condition that can cause vision changes and vision loss. There are four stages of diabetic retinopathy based on the findings of a dilated eye exam. Diabetic retinopathy ...

More information will come from 4-year results, which will be critical to assess whether there is any long-term benefit to visual acuity using aflibercept. Early treatment with anti-vascular ...